|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1486219195 |
| 003 |
DE-627 |
| 005 |
20240504234143.0 |
| 007 |
tu |
| 008 |
141029s2014 xx ||||| 00| ||ger c |
| 035 |
|
|
|a (DE-627)1486219195
|
| 035 |
|
|
|a (DE-576)416219195
|
| 035 |
|
|
|a (DE-599)BSZ416219195
|
| 035 |
|
|
|a (OCoLC)894689832
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a ger
|
| 082 |
0 |
|
|a 610
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a XH 8615
|2 rvk
|0 (DE-625)rvk/152961:13144
|
| 245 |
0 |
0 |
|a Bortezomib
|b von der Innovation zum Therapiestandard beim multiplen Myelom
|c [Hrsg. Hartmut Goldschmidt]
|
| 264 |
|
1 |
|a Stuttgart [u.a.]
|b Thieme
|c 2014
|
| 300 |
|
|
|a 11 S.
|b Ill., graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Thieme drug report
|v 2014,11
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f PEBW
|h DE-24
|x XA-DE-BW
|2 pdager
|5 DE-31
|
| 700 |
1 |
|
|a Goldschmidt, Hartmut
|d 1956-
|e Hrsg.
|0 (DE-588)102258023X
|0 (DE-627)717003809
|0 (DE-576)365637386
|4 edt
|
| 830 |
|
0 |
|a Thieme drug report
|v 2014,11
|9 2014,11
|w (DE-627)547222505
|w (DE-576)275732320
|w (DE-600)2393126-7
|x 1865-2875
|7 am
|
| 856 |
4 |
2 |
|u http://d-nb.info/1060131935/04
|m B:DE-101
|q application/pdf
|3 Inhaltsverzeichnis
|
| 936 |
r |
v |
|a XH 8615
|b Therapie (medikamentöse, physikalische Rehabilitation)
|k Medizin
|k Onkologie
|k Spezielle Onkologie
|k Nervensystem
|k Rückenmark (Neurofibromatose)
|k Allgemeine Literatur zu einem Hauptgebiet
|k Therapie (medikamentöse, physikalische Rehabilitation)
|0 (DE-627)1277031479
|0 (DE-625)rvk/152961:13144
|0 (DE-576)207031479
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20150709
|
| 993 |
|
|
|a Book
|
| 994 |
|
|
|a 2014
|
| 998 |
|
|
|g 102258023X
|a Goldschmidt, Hartmut
|m 102258023X:Goldschmidt, Hartmut
|d 910000
|d 910100
|e 910000PG102258023X
|e 910100PG102258023X
|k 0/910000/
|k 1/910000/910100/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1486219195
|e 2848420898
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"relMultPart":[{"recId":"547222505","title":[{"title":"Thieme drug report","title_sort":"Thieme drug report"}],"dispAlt":"Thieme drug report","origin":[{"publisherPlace":"Stuttgart ; New York, NY","dateIssuedDisp":"2007-2017","publisher":"Thieme","dateIssuedKey":"2007"}],"pubHistory":["1.2007,1-3; 2.2008 - 3.2009 = Nr. 1-14; 3.2009,2 - 11.2017,1"],"physDesc":[{"noteFormat":"28 cm"}],"disp":"Thieme drug report","part":{"number_sort":["2014,11"],"number":["2014,11"]},"id":{"eki":["547222505"],"issn":["1865-2875"],"zdb":["2393126-7"]},"titleAlt":[{"title":"Drug report"},{"title":"Thieme drug-report"}],"type":{"bibl":"serial"},"language":["ger","eng"]}],"type":{"bibl":"edited-book"},"person":[{"given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut","role":"edt"}],"language":["ger"],"id":{"eki":["1486219195"]},"origin":[{"publisherPlace":"Stuttgart [u.a.]","publisher":"Thieme","dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"name":{"displayForm":["[Hrsg. Hartmut Goldschmidt]"]},"physDesc":[{"extent":"11 S.","noteIll":"Ill., graph. Darst."}],"title":[{"title":"Bortezomib","title_sort":"Bortezomib","subtitle":"von der Innovation zum Therapiestandard beim multiplen Myelom"}],"recId":"1486219195"}
|
| SRT |
|
|
|a BORTEZOMIB2014
|
